2014

1) Giles-Vernick T, Owona-Ntsama J, Landier J, Eyangoh S. The puzzle of Buruli ulcer transmission, ethno-ecological history and the end of "love" in the Akonolinga district, Cameroon.  Soc Sci Med. 2014 Mar 12. pii: S0277-9536(14)00169-5. doi: 10.1016/j.socscimed.2014.03.008. [Epub ahead of print]. Abstract

2) Garchitorena A, Roche B, Kamgang R, Ossomba J, Babonneau J, Landier J, Fontanet A, Flahault A, Eyangoh S, Guégan JF, Marsollier L. Mycobacterium ulcerans ecological dynamics and its association with freshwater ecosystems and aquatic communities: results from a 12-month environmental survey in Cameroon. PLoS Negl Trop Dis. 2014 May 15;8(5):e2879. doi: 10.1371/journal.pntd.0002879. eCollection 2014. Abstract

3) Phillips RO, Sarfo FS, Landier J, Oldenburg R, Frimpong M, Wansbrough-Jones M, Abass K, Thompson W, Forson M, Fontanet A, Niang F, Demangel C. Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease.  PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2786. doi: 10.1371/journal.pntd.0002786. eCollection 2014. Abstract

4) Supervie V, Viard JP, Costagliola D, Breban R. Heterosexual Risk of HIV transmission per Sexual Act Under Combined Antiretroviral Therapy: Systematic Review and Bayesian Modeling. Clin Infect Dis. 2014 Apr 9. pii: ciu223. [Epub ahead of print]. Abstract

5) Mercier-Delarue S, Vray M, Plantier JC, Maillard T, Adjout Z, de Olivera F, Schnepf N, Maylin S, Simon F, Delaugerre C. Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spots. J Clin Microbiol. 2014 Jan;52(1):52-6. doi: 10.1128/JCM.01848-13. Epub 2013 Oct 16. Abstract

6) Jauréguiberry S, Ndour PA, Roussel C, Ader F, Safeukui I, Nguyen M, Biligui S, Ciceron L, Mouri O, Kendjo E, Bricaire F, Vray M, Angoulvant A, Mayaux J, Haldar K, Mazier D, Danis M, Caumes E, Thellier M, Buffet P. Post-artesunate delayed hemolysis is a predictable event related to the live-saving effect of artemisinins. Blood. 2014 May 23. pii: blood-2014-02-555953. [Epub ahead of print]. Abstract

7) Paireau J, Maïnassara HB, Jusot J-F, Collard J-M, Idi I, Moulia-Pelat JP, Mueller J, Fontanet A. Spatio-Temporal Factors Associated withMeningococcal Meningitis Annual Incidence at the Health Center Level in Niger, 2004-2010. PLoS Neglected Tropical Diseases 2014;8(5):e2899. doi:10.1371/journal.pntd.0002899. Abstract

8) Rachas A, Nakouné E, Bouscaillou J, Paireau J, Selekon B, Senekian D, Fontanet A, Kazanji M. Timeliness of yellow fever surveillance, Central African Republic. Emerg Infect Dis 2014; 20(6):1004-1008. doi:10.3201/eid2006.130671. Abstract

9) Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, Borand L, Prak N, Kim C, Lak KK, Hak C, Dim B, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX; for the CAMELIA (ANRS 1295-CIPRA KH001) Study Team. Causes and Determinants of Mortality in HIV-Infected Adults With Tuberculosis: An Analysis From the CAMELIA ANRS 1295-CIPRA KH001 Randomized Trial. Clin Infect Dis. 2014 Apr 23. pii: ciu283. [Epub ahead of print]. Abstract

10) Borand L, Madec Y, Laureillard D, Chou M, Marcy O, Pheng P, Prak N, Kim C, Lak KK, Hak C, Dim B, Nerrienet E, Fontanet A, Sok T, Goldfeld AE, Blanc FX, Taburet AM. Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial).  PLoS One. 2014 Mar 7;9(3):e90350. doi: 10.1371/journal.pone.0090350. eCollection 2014. Abstract

11) Laird ME, Mohsen A, Duffy D, Mamdouh R, LeFouler L, Casrouge A, El-Daly M, Rafik M, Abdel-Hamid M, Soulier A, Pawlotsky JM, Hézode C, Rosa I, Renard P, Mohamed MK, Bonnard P, Izopet J, Mallet V, Pol S, Albert ML, Fontanet A. Apolipoprotein H expression is associated with IL28B genotype and viral clearance in Hepatitis C virus infection.. J Hepatol. 2014 Jun 3. pii: S0168-8278(14)00388-2. doi: 10.1016/j.jhep.2014.05.040. [Epub ahead of print]. Abstract

12) Betsem E, Cassar O, Afonso PV, Fontanet A, Froment A, Gessain A. Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon. PLoS Negl Trop Dis. 2014 May 15;8(5):e2851. doi: 10.1371/journal.pntd.0002851. eCollection 2014. Abstract

13) Cousien A, Obach D, Deuffic-Burban S, Mostafa A, Esmat G, Canva V, El Kassas M, El-Sayed M, Anwar WA, Fontanet A, Mohamed MK, Yazdanpanah Y. Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt. BMC Med Res Methodol. 2014 Mar 17;14:39. doi: 10.1186/1471-2288-14-39. Abstract

14) Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y. Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt. Clin Infect Dis. 2014 Apr;58(8):1064-71. doi: 10.1093/cid/ciu066. Epub 2014 Feb 7. Abstract

15) Duffy D, Mamdouh R, Laird M, Soneson C, Le Fouler L, El-Daly M, Casrouge A, Decalf J, Abbas A, Eldin NS, Fontes M, Abdel-Hamid M, Mohamed MK, Rafik M, Fontanet A, Albert ML. The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis. Hepatology. 2014 Apr;59(4):1273-82. doi: 10.1002/hep.26901. Epub 2014 Feb 18. Abstract

16) Féray C, Bouscaillou J, Falissard B, Mohamed MK, Arafa N, Bakr I, El-Hoseiny M, Daly ME, El-Kafrawy S, Plancoulaine S, Abdel-Hamid M, Thiers V, Fontanet A. A novel method to identify routes of hepatitis C virus transmission. PLoS One. 2014 Jan 23;9(1):e86098. doi: 10.1371/journal.pone.0086098. eCollection 2014. Abstract

17) Penot P, Héma A, Bado G, Kaboré F, Soré I, Sombié D, Traoré JR, Guiard-Schmid JB, Fontanet A, Slama L, Bruno Sawadogo A, Laurent C. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso. J Int AIDS Soc. 2014 Jan 15;17:18646. doi: 10.7448/IAS.17.1.18646. eCollection 2014. Abstract

18) Thursz M, Fontanet A. HCV transmission in industrialized countries and resource-constrained areas. Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):28-35. doi: 10.1038/nrgastro.2013.179. Epub 2013 Oct 1. Abstract

19) Comboroure JC, Mueller JE. Perception of vaccination and role of the pharmacist: A survey among final year pharmacy students in France. Ann Pharm Fr. 2014 Mar;72(2):122-31. doi: 10.1016/j.pharma.2013.10.001. Epub 2013 Nov 20. Abstract

20) Yaro S, Njanpop-Lafourcade BM, Drabo A, Idohou RS, Kroman SS, Sanou O, Traoré Y, Sangaré L, Diagbouga SP, Koeck JL, Borrow R, Gessner BD, Mueller JE. Antipneumococcal seroprevalence and pneumococcal carriage during a meningococcal epidemic in Burkina Faso, 2006. J Infect Dis. 2014 Apr 15;209(8):1241-50. doi: 10.1093/infdis/jit641. Epub 2013 Nov 25. Abstract

21) Garenne M, Hohmann S. Gender saturation in the southern caucasus: family composition and sex-selective abortion.  j biosoc sci. 2014 feb 21:1-11. [epub ahead of print]. Abstract

22) Garenne M. Prospects for automated diagnosis of verbal autopsies.  BMC Med. 2014 Feb 4;12:18. doi: 10.1186/1741-7015-12-18. Abstract

23) Dervaux B, Baseilhac E, Fagon JY; participants of round table n°4 of Giens XXIX : Biot C, Blachier C, Braun E, Debroucker F, Detournay B, Ferretti C, Granger M, Jouan-Flahault C, Lussier MD, Meyer A, Muller S, Pigeon M, De Sahb R, Sannié T, Sapède C, Vray M. Medico-economic Evaluation of Healthcare Products. Methodology for Defining a Significant Impact on French Health Insurance Costs and Selection of Benchmarks for Interpreting Results. Therapie. 2014 7-8;69(4):331-338. Epub 2014 Aug 12. Abstract

24) Pivette M, Mueller JE, Crépey P, Bar-Hen A. Surveillance of gastrointestinal disease in France using drug sales data. Epidemics. 2014 Sep;8:1-8. doi: 10.1016/j.epidem.2014.05.001. Epub 2014 May 20. Abstact

25) Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, Hassan AB, Abdel-Hamid M, El-Daly M, Gamal ME, El Kassas M, Bedossa P, Carrat F, Fontanet A, Esmat G. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt. J Viral Hepat. 2014 Jul 30. doi: 10.1111/jvh.12285. [Epub ahead of print] Abstract

26) R. Breban, N. Arafa, S. Leroy, A. Mostafa, I. Bakr, L. Tondeur, M. Abdel-Hamid, W. Doss, G. Esmat, M.K. Mohamed and A. Fontanet. Modelling the impact of preventive and curative interventions on HCV transmission in a high prevalence setting: The case of Egypt, Lancet Glob. Health 2(9), e541-e549 (2014); doi:10.1016/S2214-109X(14)70188-3. Abstract

27) Roche B, Broutin H, Choisy M, Godreuil S, de Magny GC, Chevaleyre Y, Zucker JD, Breban R, Cazelles B, Simard F. The niche reduction approach: an opportunity for optimal control of infectious diseases in low-income countries? BMC Public Health. 2014 Jul 25;14:753. doi: 10.1186/1471-2458-14-753. Abstract

28) Garenne M, Gakusi E. (2014). Résilience du Rwanda aux chocs des années 1990 : une perspective démographique. Ethique et Economie ; 11(1) : pp 16-28. Abstract

29) Garenne M. Demographic Evidence of Sex Differences in Vulnerability to Infectious Diseases. J Infect Dis. 2014 Aug 11. pii: jiu448. [Epub ahead of print] No abstract available.

30) Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, Fontanet A, Bretagne S, Dromer F; French Mycosis Study Group. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med. 2014 Sep;40(9):1303-12. doi: 10.1007/s00134-014-3408-3. Epub 2014 Aug 6. Abstract

31) Duriez M, Quillay H, Madec Y, El Costa H, Cannou C, Marlin R, de Truchis C, Rahmati M, Barré-Sinoussi F, Nugeyre MT, Menu E. Human decidual macrophages and NK cells differentially express Toll-like receptors and display distinct cytokine profiles upon TLR stimulation. Front Microbiol. 2014 Jul 1;5:316. doi: 10.3389/fmicb.2014.00316. eCollection 2014. Abstract

32) Jacquelin B, Petitjean G, Kunkel D, Liovat AS, Jochems SP, Rogers KA, Ploquin MJ, Madec Y, Barré-Sinoussi F, Dereuddre-Bosquet N, Lebon P, Le Grand R, Villinger F, Müller-Trutwin M. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 2014 Jul 3;10(7):e1004241. doi: 10.1371/journal.ppat.1004241. eCollection 2014 Jul. Abstract

33) Jordi Landier, Arnaud Fontanet, Gaëtan Texier (2014) Defining and targeting high-risk populations in Buruli ulcer: a challenge with clinical, epidemiological and public health relevance. Correspondence, The Lancet Global Health, in press.

34) Pommelet V, Vincent QB, Ardant MF, Adeye A, Tanase A, Tondeur L, Rega A, Landier J, Marion E, Alcaïs A, Marsollier L, Fontanet A, Chauty A. Findings in Patients From Benin With Osteomyelitis and Polymerase Chain Reaction-Confirmed Mycobacterium ulcerans Infection. Clin Infect Dis. 2014 Jul 21. pii: ciu584. [Epub ahead of print] Abstract

36) Landier J, Gaudart J, Carolan K, Lo Seen D, Guégan JF, Eyangoh S, Fontanet A, Texier G. Spatio-temporal Patterns and Landscape-Associated Risk of Buruli Ulcer in Akonolinga, Cameroon. PLoS Negl Trop Dis. 2014 Sep 4;8(9):e3123. doi: 10.1371/journal.pntd.0003123. eCollection 2014 Sep. Abstract

Mis à jour le 10/10/2014

Contact

Unité d'Epidémiologie des Maladies Emergentes


Institut Pasteur
25-28 rue du Dr Roux
75724 Paris Cedex 15


Tél : +33 (0)1 40 61 37 66
Fax: +33 (0)1 45 68 88 7

Email: ueme@pasteur.fr

Où nous trouver ?

plan.jpg

Agenda

Tout l'agenda